NEW YORK (AP) -- Australian bio-nanotech company Psivida Ltd. said Wednesday it signed an exclusive research and license agreement for its drug delivery technology with Pfizer Inc.
Shares of Psivida rose $1.16, or 56.9 percent, to $3.20 in premarket trading
PSD
psivida limited
NEW YORK (AP) -- Australian bio-nanotech company Psivida Ltd....
Add to My Watchlist
What is My Watchlist?